Select Page
Dr Debnarayan Dutta

Dr Debnarayan Dutta

MBBS, MD, PhD (Radiotherapy)

Department : Radiation Oncology
Exp: 19 yrs
Designation: Sr. Consultant Radiation Oncologist Clinical Director
Languages: English, Hindi & Bangla
Med Reg No: 557703 of WBMC

Day time OPD:
MON - SAT : 9:00 AM - 4:00 PM

Location: Hitec City

About the Doctor

Dr Debnarayan Dutta is a Sr. Consultant Radiation Oncologist & Clinical Director at Yashoda Hospitals, Hitec City. With a career spanning over two decades, Dr Dutta has amassed extensive experience and expertise in the treatment of cancer through radiation therapy, particularly specialising in advanced techniques such as CyberKnife and stereotactic radiosurgery. His focus area of specialisation is neurooncology, radiosurgery and head & neck cancer. He has more than 150 indexed publications, serves as a reviewer for many indexed journals, and is the author of four books. He has done his PhD in molecular profiling of Indian head & neck cancer patients treated with radical intent image guided radiation therapy.

Educational Qualifications

  • 2023: PhD, VIT, Vellore
  • 2008 to 2010: Fellowship in Head & Neck IMRT
  • 2006 to 2008: Fellowship in Neuro-Oncology
  • 2003 to 2006: MD (Radiation Oncology), Calcutta University, Kolkata

Experience

  • Present: Sr. Consultant Radiation Oncologist, Clinical Director, Yashoda Hospitals, Hitec City.
  • 2017 to 2025: Professor & Head, Radiation Oncology & Cyberknife In-Charge, Amrita Hospital, Kochi
  • 2010 to 2016: Senior Consultant, Radiation Oncology, Apollo Cancer Hospital, Chennai
  • 2006 to 2010:Senior Registrar in Radiation Oncology, Tata Memorial Hospital, Mumbai

Services offered

  • MR Linac Radiosurgery
  • Radiation therapy, IMRT, IGRT
  • Conventional Radiation Therapy

Special Interest and Expertise

  • Radiosurgery
  • Stereotactic Body Radiation Therapy (SBRT)
  • Neurooncology
  • Head & Neck Cancer
  • ASCO merit award at Chicago in 2008
  • Participant at the 'Hoshino Young Investigator Award' at Yokahama 2009
  • Neucletron Fellowship award in AROICON 2010 at Patna, India
  • Presidential award for Best Clinical researcher' for the year 2024 by the Indian Society of Neurooncology (ISNO)
  • Introduced the CyberKnife Radiosurgery facility in India in the year 2010 at Apollo Speciality Cancer Hospital, Chennai. At present, in charge of the CyberKnife radiosurgery facility at Amrita Institute, Kochi, and have treated more than 1500 patients at Kochi with radiosurgery
  • 150 Indexed publication, three book chapters, reviewer and co-editor of multiple journals
  • Invited speaker about CyberKnife / Radiosurgery and radiation oncology in more than 250 meetings in India and abroad.
  • AROI
  • ISNO
  • MCI
  • Validation of Combs Prognostic Scoring System in Indian Recurrent Glioma Patients Treated with Re-irradiation
    Dutta D, Jose M, Kalavagunta S, Annexe H. Radiation Oncology Journal, 2024; 42(1):32–42. DOI: 10.3857/roj.2023.00542
  • Audit of Presentation, Primary Site and Pattern of Treatment in 778 Indian Patients with Brain Metastasis Over 15 Years (2007–2022)
    Dutta D, Surendran HP, Kalavagunta S, Sasidharan A, Narmadha MP. Neurology India. 2024. (In Press)
  • Efficacy of Memantine in Preventing Neurocognitive Dysfunction Induced by Radiation Therapy in Patients with Brain Metastases: A Systematic Review of Clinical Trials Surendran HP, Sah SK, Louis DM, Kalavagunta S, Poornachary NM, Joy SC, Dutta D. Seminars in Oncology. 2023; 50(3–5):113–122. DOI: 10.1053/j.seminoncol.2023.09.004
  • Extramedullary Plasmacytoma of the Larynx: A Case Report Gupte A, Sasidharan A, Nair A, Dutta D. Journal of Cancer Research and Therapeutics. 2024; 20(1):493–495. DOI: 10.4103/jcrt.JCRT_1640_20
  • Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 Prostate Cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy. Clinical Oncology (Royal College of Radiologists, Great Britain). 2023.
  • 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations
  • Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS Dutta D, Reddy SK, Kamath RK, Sreenija Y, Nair H, Sasidharan A, Remesan Nair RA, Pushpuja KU, Kannan R, Edappattu A, Haridas NK, Jose WM, Keechilat P. Neurology India. 2023; 71(1):62–71. DOI: 10.4103/0028-3886.370470
  • Hypofractionated Radiotherapy for Stage I Squamous Cell Carcinoma of the Glottis: An Experience with 60 Gy in 20 Fractions
    Pushpaja KU, Nair AR, Mazhoor SN, Lakshmi JS, Dutta D. Iranian Journal of Medical Physics. 2023; 20(4):226–232. DOI: 10.22038/IJMP.2022.62774.2073
  • Role of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Detection of Portal Vein Tumour Thrombosis in Hepatocellular Carcinoma: A Case Report Yarlagadda S, Sasidharan A, Sundaram S, Dutta D. Journal of Gastroenterology & Hepatology Reports. 2022. DOI: 10.47363/JGHR/2022(3)129

Posters/Papers/Oral Presentations

  • Many national & international conference papers, presentations and posters

FAQ's

    Dr Debnarayan Dutta holds the following qualifications: MBBS, MD, PhD (Radiotherapy)

    Dr Debnarayan Dutta is a specialist in providing advanced radiation treatments such as MR Linac Radiosurgery, Radiation therapy, IMRT, IGRT and also Conventional Radiation Therapy in suitable cases.

    Dr Debnarayan Dutta practices at Yashoda Hospitals, Hitec City.

    You can schedule an appointment with Dr Debnarayan Dutta for both an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.